Application 202016
- Type
- ANDA
- Sponsor
- NOVAST LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MELAMISA | DROSPIRENONE; ETHINYL ESTRADIOL | TABLET;ORAL | 3MG;0.02MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 75834-116 | Drospirenone and ethinyl estradiol | Drospirenone and ethinyl estradiol | Nivagen Pharmaceuticals, Inc. | ANDA | Current |
| 75834-116 | Drospirenone and ethinyl estradiol | Drospirenone and ethinyl estradiol | Nivagen Pharmaceuticals, Inc. | ANDA | Current |